TY  - JOUR
AU  - Pereyaslov, D.
AU  - Rosin, P.
AU  - Palm, D.
AU  - Zeller, H.
AU  - Gross, D.
AU  - Brown, C.S.
AU  - Struelens, M.J.
AU  - Robo, Alma
AU  - Hatibi, I.H.
AU  - Alis, J.C.
AU  - Sargsyan, S.
AU  - Gurbanov, S.
AU  - Gribkova, N.
AU  - van Ranst, M.
AU  - Ieven, G.
AU  - Patteet, S.
AU  - Tomić, S.
AU  - Korsun, N.
AU  - Drazenović, V.
AU  - Pieridou-Bagkatzouni, D.
AU  - Jirincova, H.
AU  - Havlickova, M.
AU  - Fomsgaard, A.
AU  - Rae, K.
AU  - Lappalainen, M.
AU  - Ikonen, N.
AU  - Lina, B.
AU  - van der Werf, S.
AU  - Manuguerra, J.-C.
AU  - Machablishvili, A.
AU  - Eickmann, M.
AU  - Wolff, T.
AU  - Dobler, G.
AU  - Schmidt-Chanasit, J.
AU  - Drosten, C.
AU  - Papa, Anna
AU  - Mentis, Andreas F.
AU  - Kis, Z.
AU  - Löve, A.
AU  - Coughlan, S.
AU  - Mandelboim, M.
AU  - Capobianchi, M.R.
AU  - Landini, M.P.
AU  - Baldanti, F.
AU  - Palu, G.
AU  - Ghisetti, V.
AU  - Donatelli, I.
AU  - Nusupbayeva, G.
AU  - Tokhtabakiyeva, Z.
AU  - Kasymbekova, Kalia
AU  - Storozenko, J.
AU  - Erne, S.
AU  - Griskevicius, A.
AU  - Opp, M.
AU  - Barbara, C.
AU  - Vratnica, Z.
AU  - Reusken, C.
AU  - Dudman, S.G.
AU  - Hungnes, O.
AU  - Pancer, K.
AU  - Guiomar, R.
AU  - Eder, V.
AU  - Lupulescu, Emilia
AU  - Yatsyshina, S.
AU  - Pisareva, M.
AU  - Buzitskaya, Z.
AU  - Sergeev, A.
AU  - Nedeljković, Jasminka
AU  - Staroňová, E.
AU  - Županc, T.A.
AU  - Petrovec, M.
AU  - Korva, M.
AU  - Prosenc, K.
AU  - Casas, I.
AU  - Gaines, H.
AU  - Cherpillod, P.
AU  - Zakirova, N.
AU  - Bosevska, G.
AU  - Altas, B.
AU  - Ciblak, M.
AU  - Ciblak, M.
AU  - Mironenko, A.
AU  - Dykhanovska, T.
AU  - Demchyshyna, Irina V.
AU  - Bermingham, A.
AU  - Rakhimov, R.
PY  - 2014
UR  - http://intor.torlakinstitut.com/handle/123456789/416
AB  - Since September 2012, over 90 cases of respiratory disease caused by a novel coronavirus, now named Middle East respiratory syndrome coronavirus (MERS-CoV), have been reported in the Middle East and Europe. To ascertain the capabilities and testing experience of national reference laboratories across the World Health Organization (WHO) European Region to detect this virus, the European Centre for Disease Prevention and Control (ECDC) and the WHO Regional Office for Europe conducted a joint survey in November 2012 and a follow-up survey in June 2013. In 2013, 29 of 52 responding WHO European Region countries and 24 of 31 countries of the European Union/European Economic Area (EU/EEA) had laboratory capabilities to detect and confirm MERS-CoV cases, compared with 22 of 46 and 18 of 30 countries, respectively, in 2012. By June 2013, more than 2,300 patients had been tested in 23 countries in the WHO European Region with nine laboratory-confirmed MERS-CoV cases. These data indicate that the Region has developed significant capability to detect this emerging virus in accordance with WHO and ECDC guidance. However, not all countries had developed capabilities, and the needs to do so should be addressed. This includes enhancing collaborations between countries to ensure diagnostic capabilities for surveillance of MERS-CoV infections across the European Region.
PB  - European Centre for Disease Prevention and Control (ECDC)
T2  - Eurosurveillance
T1  - Laboratory capability and surveillance testing for middle east respiratory syndrome coronavirus infection in the who European region, June 2013
IS  - 40
VL  - 19
DO  - 10.2807/1560-7917.ES2014.19.40.20923
ER  - 

@article{
author = "Pereyaslov, D. and Rosin, P. and Palm, D. and Zeller, H. and Gross, D. and Brown, C.S. and Struelens, M.J. and Robo, Alma and Hatibi, I.H. and Alis, J.C. and Sargsyan, S. and Gurbanov, S. and Gribkova, N. and van Ranst, M. and Ieven, G. and Patteet, S. and Tomić, S. and Korsun, N. and Drazenović, V. and Pieridou-Bagkatzouni, D. and Jirincova, H. and Havlickova, M. and Fomsgaard, A. and Rae, K. and Lappalainen, M. and Ikonen, N. and Lina, B. and van der Werf, S. and Manuguerra, J.-C. and Machablishvili, A. and Eickmann, M. and Wolff, T. and Dobler, G. and Schmidt-Chanasit, J. and Drosten, C. and Papa, Anna and Mentis, Andreas F. and Kis, Z. and Löve, A. and Coughlan, S. and Mandelboim, M. and Capobianchi, M.R. and Landini, M.P. and Baldanti, F. and Palu, G. and Ghisetti, V. and Donatelli, I. and Nusupbayeva, G. and Tokhtabakiyeva, Z. and Kasymbekova, Kalia and Storozenko, J. and Erne, S. and Griskevicius, A. and Opp, M. and Barbara, C. and Vratnica, Z. and Reusken, C. and Dudman, S.G. and Hungnes, O. and Pancer, K. and Guiomar, R. and Eder, V. and Lupulescu, Emilia and Yatsyshina, S. and Pisareva, M. and Buzitskaya, Z. and Sergeev, A. and Nedeljković, Jasminka and Staroňová, E. and Županc, T.A. and Petrovec, M. and Korva, M. and Prosenc, K. and Casas, I. and Gaines, H. and Cherpillod, P. and Zakirova, N. and Bosevska, G. and Altas, B. and Ciblak, M. and Ciblak, M. and Mironenko, A. and Dykhanovska, T. and Demchyshyna, Irina V. and Bermingham, A. and Rakhimov, R.",
year = "2014",
abstract = "Since September 2012, over 90 cases of respiratory disease caused by a novel coronavirus, now named Middle East respiratory syndrome coronavirus (MERS-CoV), have been reported in the Middle East and Europe. To ascertain the capabilities and testing experience of national reference laboratories across the World Health Organization (WHO) European Region to detect this virus, the European Centre for Disease Prevention and Control (ECDC) and the WHO Regional Office for Europe conducted a joint survey in November 2012 and a follow-up survey in June 2013. In 2013, 29 of 52 responding WHO European Region countries and 24 of 31 countries of the European Union/European Economic Area (EU/EEA) had laboratory capabilities to detect and confirm MERS-CoV cases, compared with 22 of 46 and 18 of 30 countries, respectively, in 2012. By June 2013, more than 2,300 patients had been tested in 23 countries in the WHO European Region with nine laboratory-confirmed MERS-CoV cases. These data indicate that the Region has developed significant capability to detect this emerging virus in accordance with WHO and ECDC guidance. However, not all countries had developed capabilities, and the needs to do so should be addressed. This includes enhancing collaborations between countries to ensure diagnostic capabilities for surveillance of MERS-CoV infections across the European Region.",
publisher = "European Centre for Disease Prevention and Control (ECDC)",
journal = "Eurosurveillance",
title = "Laboratory capability and surveillance testing for middle east respiratory syndrome coronavirus infection in the who European region, June 2013",
number = "40",
volume = "19",
doi = "10.2807/1560-7917.ES2014.19.40.20923"
}

Pereyaslov, D., Rosin, P., Palm, D., Zeller, H., Gross, D., Brown, C.S., Struelens, M.J., Robo, A., Hatibi, I.H., Alis, J.C., Sargsyan, S., Gurbanov, S., Gribkova, N., van Ranst, M., Ieven, G., Patteet, S., Tomić, S., Korsun, N., Drazenović, V., Pieridou-Bagkatzouni, D., Jirincova, H., Havlickova, M., Fomsgaard, A., Rae, K., Lappalainen, M., Ikonen, N., Lina, B., van der Werf, S., Manuguerra, J.-C., Machablishvili, A., Eickmann, M., Wolff, T., Dobler, G., Schmidt-Chanasit, J., Drosten, C., Papa, A., Mentis, A. F., Kis, Z., Löve, A., Coughlan, S., Mandelboim, M., Capobianchi, M.R., Landini, M.P., Baldanti, F., Palu, G., Ghisetti, V., Donatelli, I., Nusupbayeva, G., Tokhtabakiyeva, Z., Kasymbekova, K., Storozenko, J., Erne, S., Griskevicius, A., Opp, M., Barbara, C., Vratnica, Z., Reusken, C., Dudman, S.G., Hungnes, O., Pancer, K., Guiomar, R., Eder, V., Lupulescu, E., Yatsyshina, S., Pisareva, M., Buzitskaya, Z., Sergeev, A., Nedeljković, J., Staroňová, E., Županc, T.A., Petrovec, M., Korva, M., Prosenc, K., Casas, I., Gaines, H., Cherpillod, P., Zakirova, N., Bosevska, G., Altas, B., Ciblak, M., Ciblak, M., Mironenko, A., Dykhanovska, T., Demchyshyna, I. V., Bermingham, A.,& Rakhimov, R.. (2014). Laboratory capability and surveillance testing for middle east respiratory syndrome coronavirus infection in the who European region, June 2013. in Eurosurveillance
European Centre for Disease Prevention and Control (ECDC)., 19(40).
https://doi.org/10.2807/1560-7917.ES2014.19.40.20923

Pereyaslov D, Rosin P, Palm D, Zeller H, Gross D, Brown C, Struelens M, Robo A, Hatibi I, Alis J, Sargsyan S, Gurbanov S, Gribkova N, van Ranst M, Ieven G, Patteet S, Tomić S, Korsun N, Drazenović V, Pieridou-Bagkatzouni D, Jirincova H, Havlickova M, Fomsgaard A, Rae K, Lappalainen M, Ikonen N, Lina B, van der Werf S, Manuguerra J, Machablishvili A, Eickmann M, Wolff T, Dobler G, Schmidt-Chanasit J, Drosten C, Papa A, Mentis AF, Kis Z, Löve A, Coughlan S, Mandelboim M, Capobianchi M, Landini M, Baldanti F, Palu G, Ghisetti V, Donatelli I, Nusupbayeva G, Tokhtabakiyeva Z, Kasymbekova K, Storozenko J, Erne S, Griskevicius A, Opp M, Barbara C, Vratnica Z, Reusken C, Dudman S, Hungnes O, Pancer K, Guiomar R, Eder V, Lupulescu E, Yatsyshina S, Pisareva M, Buzitskaya Z, Sergeev A, Nedeljković J, Staroňová E, Županc T, Petrovec M, Korva M, Prosenc K, Casas I, Gaines H, Cherpillod P, Zakirova N, Bosevska G, Altas B, Ciblak M, Ciblak M, Mironenko A, Dykhanovska T, Demchyshyna IV, Bermingham A, Rakhimov R. Laboratory capability and surveillance testing for middle east respiratory syndrome coronavirus infection in the who European region, June 2013. in Eurosurveillance. 2014;19(40).
doi:10.2807/1560-7917.ES2014.19.40.20923 .

Pereyaslov, D., Rosin, P., Palm, D., Zeller, H., Gross, D., Brown, C.S., Struelens, M.J., Robo, Alma, Hatibi, I.H., Alis, J.C., Sargsyan, S., Gurbanov, S., Gribkova, N., van Ranst, M., Ieven, G., Patteet, S., Tomić, S., Korsun, N., Drazenović, V., Pieridou-Bagkatzouni, D., Jirincova, H., Havlickova, M., Fomsgaard, A., Rae, K., Lappalainen, M., Ikonen, N., Lina, B., van der Werf, S., Manuguerra, J.-C., Machablishvili, A., Eickmann, M., Wolff, T., Dobler, G., Schmidt-Chanasit, J., Drosten, C., Papa, Anna, Mentis, Andreas F., Kis, Z., Löve, A., Coughlan, S., Mandelboim, M., Capobianchi, M.R., Landini, M.P., Baldanti, F., Palu, G., Ghisetti, V., Donatelli, I., Nusupbayeva, G., Tokhtabakiyeva, Z., Kasymbekova, Kalia, Storozenko, J., Erne, S., Griskevicius, A., Opp, M., Barbara, C., Vratnica, Z., Reusken, C., Dudman, S.G., Hungnes, O., Pancer, K., Guiomar, R., Eder, V., Lupulescu, Emilia, Yatsyshina, S., Pisareva, M., Buzitskaya, Z., Sergeev, A., Nedeljković, Jasminka, Staroňová, E., Županc, T.A., Petrovec, M., Korva, M., Prosenc, K., Casas, I., Gaines, H., Cherpillod, P., Zakirova, N., Bosevska, G., Altas, B., Ciblak, M., Ciblak, M., Mironenko, A., Dykhanovska, T., Demchyshyna, Irina V., Bermingham, A., Rakhimov, R., "Laboratory capability and surveillance testing for middle east respiratory syndrome coronavirus infection in the who European region, June 2013" in Eurosurveillance, 19, no. 40 (2014),
https://doi.org/10.2807/1560-7917.ES2014.19.40.20923 . .

TY  - JOUR
AU  - Fernandez-García, M.D.
AU  - Negredo, A.
AU  - Papa, Anna
AU  - Donoso-Mantke, O.
AU  - Niedrig, M.
AU  - Zeller, H.
AU  - Tenorio, A.
AU  - Franco, L.
AU  - Aberle, S.
AU  - van Esbroeck, M.
AU  - Christova, I.
AU  - Markotić, A.
AU  - Kurolt, I.-C.
AU  - Zelena, H.
AU  - Golovljova, I.
AU  - Pannetier, D.
AU  - Charrel, R.
AU  - Schmidt-Chanasit, J.
AU  - Wölfel, R.
AU  - Capobianchi, M.R.
AU  - Jakupi, X.
AU  - Storozenko, J.
AU  - Griskevicius, A.
AU  - Bosevska, G.
AU  - Muscat, C.
AU  - Schutten, M.
AU  - Dudman, S.G.
AU  - Alves, M.J.
AU  - Ceianu, C.
AU  - Platonov, A.
AU  - Božović, Bojana
AU  - Klempa, B.
AU  - Avsić, T.
AU  - Tenorio, A.
AU  - Lundkvist, A.
AU  - Cherpillod, P.
AU  - Korukluoglu, G.
AU  - Brown, D.
AU  - Brooks, T.
PY  - 2014
UR  - http://intor.torlakinstitut.com/handle/123456789/412
AB  - Crimean-Congo haemorrhagic fever (CCHF) is an infectious viral disease that has (re-)emerged in the last decade in south-eastern Europe, and there is a risk for further geographical expansion to western Europe. Here we report the results of a survey covering 28 countries, conducted in 2012 among the member laboratories of the European Network for Diagnostics of 'Imported' Viral Diseases (ENIVD) to assess laboratory preparedness and response capacities for CCHF. The answers of 31 laboratories of the European region regarding CCHF case definition, training necessity, biosafety, quality assurance and diagnostic tests are presented. In addition, we identified the lack of a Regional Reference Expert Laboratory in or near endemic areas. Moreover, a comprehensive review of the biosafety level suitable to the reality of endemic areas is needed. These issues are challenges that should be addressed by European public health authorities. However, all respondent laboratories have suitable diagnostic capacities for the current situation.
PB  - European Centre for Disease Prevention and Control (ECDC)
T2  - Eurosurveillance
T1  - European survey on laboratory preparedness, response and diagnostic capacity for crimean-congo haemorrhagic fever, 2012
IS  - 26
VL  - 19
DO  - 10.2807/1560-7917.ES2014.19.26.20844
ER  - 

@article{
author = "Fernandez-García, M.D. and Negredo, A. and Papa, Anna and Donoso-Mantke, O. and Niedrig, M. and Zeller, H. and Tenorio, A. and Franco, L. and Aberle, S. and van Esbroeck, M. and Christova, I. and Markotić, A. and Kurolt, I.-C. and Zelena, H. and Golovljova, I. and Pannetier, D. and Charrel, R. and Schmidt-Chanasit, J. and Wölfel, R. and Capobianchi, M.R. and Jakupi, X. and Storozenko, J. and Griskevicius, A. and Bosevska, G. and Muscat, C. and Schutten, M. and Dudman, S.G. and Alves, M.J. and Ceianu, C. and Platonov, A. and Božović, Bojana and Klempa, B. and Avsić, T. and Tenorio, A. and Lundkvist, A. and Cherpillod, P. and Korukluoglu, G. and Brown, D. and Brooks, T.",
year = "2014",
abstract = "Crimean-Congo haemorrhagic fever (CCHF) is an infectious viral disease that has (re-)emerged in the last decade in south-eastern Europe, and there is a risk for further geographical expansion to western Europe. Here we report the results of a survey covering 28 countries, conducted in 2012 among the member laboratories of the European Network for Diagnostics of 'Imported' Viral Diseases (ENIVD) to assess laboratory preparedness and response capacities for CCHF. The answers of 31 laboratories of the European region regarding CCHF case definition, training necessity, biosafety, quality assurance and diagnostic tests are presented. In addition, we identified the lack of a Regional Reference Expert Laboratory in or near endemic areas. Moreover, a comprehensive review of the biosafety level suitable to the reality of endemic areas is needed. These issues are challenges that should be addressed by European public health authorities. However, all respondent laboratories have suitable diagnostic capacities for the current situation.",
publisher = "European Centre for Disease Prevention and Control (ECDC)",
journal = "Eurosurveillance",
title = "European survey on laboratory preparedness, response and diagnostic capacity for crimean-congo haemorrhagic fever, 2012",
number = "26",
volume = "19",
doi = "10.2807/1560-7917.ES2014.19.26.20844"
}

Fernandez-García, M.D., Negredo, A., Papa, A., Donoso-Mantke, O., Niedrig, M., Zeller, H., Tenorio, A., Franco, L., Aberle, S., van Esbroeck, M., Christova, I., Markotić, A., Kurolt, I.-C., Zelena, H., Golovljova, I., Pannetier, D., Charrel, R., Schmidt-Chanasit, J., Wölfel, R., Capobianchi, M.R., Jakupi, X., Storozenko, J., Griskevicius, A., Bosevska, G., Muscat, C., Schutten, M., Dudman, S.G., Alves, M.J., Ceianu, C., Platonov, A., Božović, B., Klempa, B., Avsić, T., Tenorio, A., Lundkvist, A., Cherpillod, P., Korukluoglu, G., Brown, D.,& Brooks, T.. (2014). European survey on laboratory preparedness, response and diagnostic capacity for crimean-congo haemorrhagic fever, 2012. in Eurosurveillance
European Centre for Disease Prevention and Control (ECDC)., 19(26).
https://doi.org/10.2807/1560-7917.ES2014.19.26.20844

Fernandez-García M, Negredo A, Papa A, Donoso-Mantke O, Niedrig M, Zeller H, Tenorio A, Franco L, Aberle S, van Esbroeck M, Christova I, Markotić A, Kurolt I, Zelena H, Golovljova I, Pannetier D, Charrel R, Schmidt-Chanasit J, Wölfel R, Capobianchi M, Jakupi X, Storozenko J, Griskevicius A, Bosevska G, Muscat C, Schutten M, Dudman S, Alves M, Ceianu C, Platonov A, Božović B, Klempa B, Avsić T, Tenorio A, Lundkvist A, Cherpillod P, Korukluoglu G, Brown D, Brooks T. European survey on laboratory preparedness, response and diagnostic capacity for crimean-congo haemorrhagic fever, 2012. in Eurosurveillance. 2014;19(26).
doi:10.2807/1560-7917.ES2014.19.26.20844 .

Fernandez-García, M.D., Negredo, A., Papa, Anna, Donoso-Mantke, O., Niedrig, M., Zeller, H., Tenorio, A., Franco, L., Aberle, S., van Esbroeck, M., Christova, I., Markotić, A., Kurolt, I.-C., Zelena, H., Golovljova, I., Pannetier, D., Charrel, R., Schmidt-Chanasit, J., Wölfel, R., Capobianchi, M.R., Jakupi, X., Storozenko, J., Griskevicius, A., Bosevska, G., Muscat, C., Schutten, M., Dudman, S.G., Alves, M.J., Ceianu, C., Platonov, A., Božović, Bojana, Klempa, B., Avsić, T., Tenorio, A., Lundkvist, A., Cherpillod, P., Korukluoglu, G., Brown, D., Brooks, T., "European survey on laboratory preparedness, response and diagnostic capacity for crimean-congo haemorrhagic fever, 2012" in Eurosurveillance, 19, no. 26 (2014),
https://doi.org/10.2807/1560-7917.ES2014.19.26.20844 . .

TY  - JOUR
AU  - Papa, Anna
AU  - Bojović, Bojana
AU  - Antoniadis, Antonis
PY  - 2006
UR  - http://intor.torlakinstitut.com/handle/123456789/205
AB  - Hantaviruses are endemic in the Balkan Peninsula. An outbreak of hemorrhagic fever with renal syndrome occurred in 2002 in Serbia and Montenegro. The epidemiologic characteristics and genetic relatedness of Dobrava/Belgracle virus strains responsible for most cases are described.
PB  - Centers  Disease Control & Prevention, Atlanta
T2  - Emerging Infectious Diseases
T1  - Hantaviruses in Serbia and Montenegro
EP  - 1018
IS  - 6
SP  - 1015
VL  - 12
DO  - 10.3201/eid1206.051564
ER  - 

@article{
author = "Papa, Anna and Bojović, Bojana and Antoniadis, Antonis",
year = "2006",
abstract = "Hantaviruses are endemic in the Balkan Peninsula. An outbreak of hemorrhagic fever with renal syndrome occurred in 2002 in Serbia and Montenegro. The epidemiologic characteristics and genetic relatedness of Dobrava/Belgracle virus strains responsible for most cases are described.",
publisher = "Centers  Disease Control & Prevention, Atlanta",
journal = "Emerging Infectious Diseases",
title = "Hantaviruses in Serbia and Montenegro",
pages = "1018-1015",
number = "6",
volume = "12",
doi = "10.3201/eid1206.051564"
}

Papa, A., Bojović, B.,& Antoniadis, A.. (2006). Hantaviruses in Serbia and Montenegro. in Emerging Infectious Diseases
Centers  Disease Control & Prevention, Atlanta., 12(6), 1015-1018.
https://doi.org/10.3201/eid1206.051564

Papa A, Bojović B, Antoniadis A. Hantaviruses in Serbia and Montenegro. in Emerging Infectious Diseases. 2006;12(6):1015-1018.
doi:10.3201/eid1206.051564 .

Papa, Anna, Bojović, Bojana, Antoniadis, Antonis, "Hantaviruses in Serbia and Montenegro" in Emerging Infectious Diseases, 12, no. 6 (2006):1015-1018,
https://doi.org/10.3201/eid1206.051564 . .

TY  - JOUR
AU  - Papa, Anna
AU  - Papadimitriou, E.
AU  - Božović, Bojana
AU  - Antoniadis, Antonis
PY  - 2005
UR  - http://intor.torlakinstitut.com/handle/123456789/199
AB  - Crimean-Congo hemorrhagic fever (CCHF) virus causes one of the most severe diseases in humans, with a mortality rate of up to 30%. It is transmitted to humans by the bite of hard ticks or by contact with blood or tissues from human patients or infected livestock. Balkan Peninsula is an endemic region of the disease, and sporadic cases or even outbreaks are observed every year. The M RNA segment encodes for the glycoprotein precursor of two surface glycoproteins Gn and Gc. Up to now complete M RNA CCHF virus sequences have been published from strains isolated in Nigeria, China, Pakistan, Tajikistan, and Russia. In the present study, the genetic characterization of the complete nucleotide sequence of the M RNA segment of a Balkan CCHF virus strain, Kosovo/9553/2001, isolated in summer of 2001 from a human fatal case in Kosovo is reported. This is the first published complete M nucleotide sequence of a CCHF virus strain isolated in Balkans. It was found that the Balkan strain is similar to the Russian strain, both strains differing from all other completely sequenced CCHF virus strains by approximately 22% at the nucleotide level forming an independent clade in the phylogenetic tree. (C) 2005 Wiley-Liss, Inc.
PB  - Wiley, Hoboken
T2  - Journal of Medical Virology
T1  - Genetic characterization of the M RNA segment of a Balkan Crimean-Congo hemorrhagic fever virus strain
EP  - 469
IS  - 3
SP  - 466
VL  - 75
DO  - 10.1002/jmv.20290
ER  - 

@article{
author = "Papa, Anna and Papadimitriou, E. and Božović, Bojana and Antoniadis, Antonis",
year = "2005",
abstract = "Crimean-Congo hemorrhagic fever (CCHF) virus causes one of the most severe diseases in humans, with a mortality rate of up to 30%. It is transmitted to humans by the bite of hard ticks or by contact with blood or tissues from human patients or infected livestock. Balkan Peninsula is an endemic region of the disease, and sporadic cases or even outbreaks are observed every year. The M RNA segment encodes for the glycoprotein precursor of two surface glycoproteins Gn and Gc. Up to now complete M RNA CCHF virus sequences have been published from strains isolated in Nigeria, China, Pakistan, Tajikistan, and Russia. In the present study, the genetic characterization of the complete nucleotide sequence of the M RNA segment of a Balkan CCHF virus strain, Kosovo/9553/2001, isolated in summer of 2001 from a human fatal case in Kosovo is reported. This is the first published complete M nucleotide sequence of a CCHF virus strain isolated in Balkans. It was found that the Balkan strain is similar to the Russian strain, both strains differing from all other completely sequenced CCHF virus strains by approximately 22% at the nucleotide level forming an independent clade in the phylogenetic tree. (C) 2005 Wiley-Liss, Inc.",
publisher = "Wiley, Hoboken",
journal = "Journal of Medical Virology",
title = "Genetic characterization of the M RNA segment of a Balkan Crimean-Congo hemorrhagic fever virus strain",
pages = "469-466",
number = "3",
volume = "75",
doi = "10.1002/jmv.20290"
}

Papa, A., Papadimitriou, E., Božović, B.,& Antoniadis, A.. (2005). Genetic characterization of the M RNA segment of a Balkan Crimean-Congo hemorrhagic fever virus strain. in Journal of Medical Virology
Wiley, Hoboken., 75(3), 466-469.
https://doi.org/10.1002/jmv.20290

Papa A, Papadimitriou E, Božović B, Antoniadis A. Genetic characterization of the M RNA segment of a Balkan Crimean-Congo hemorrhagic fever virus strain. in Journal of Medical Virology. 2005;75(3):466-469.
doi:10.1002/jmv.20290 .

Papa, Anna, Papadimitriou, E., Božović, Bojana, Antoniadis, Antonis, "Genetic characterization of the M RNA segment of a Balkan Crimean-Congo hemorrhagic fever virus strain" in Journal of Medical Virology, 75, no. 3 (2005):466-469,
https://doi.org/10.1002/jmv.20290 . .

TY  - JOUR
AU  - Papa, Anna
AU  - Božović, Bojana
AU  - Pavlidou, V.
AU  - Papadimitriou, E.
AU  - Pelemiš, Mijomir
AU  - Antoniadis, Antonis
PY  - 2002
UR  - http://intor.torlakinstitut.com/handle/123456789/146
AB  - Crimean-Congo hemorrhagic fever virus (C-CHFV) strains were isolated from a fatal case and the attending physician in Kosovo, Yugoslavia. Early, rapid diagnosis of the disease was achieved by reverse transcription-polymerase chain reaction. The physician was successfully treated with oral ribavirin. These cases yielded the first genetically studied C-CHFV human isolates in the Balkans.
PB  - Centers for Disease Control and Prevention (CDC)
T2  - Emerging Infectious Diseases
T1  - Genetic detection and isolation of Crimean-Congo hemorrhagic fever virus, Kosovo, Yugoslavia
EP  - 854
IS  - 8
SP  - 852
VL  - 8
DO  - 10.3201/eid0808.010448
ER  - 

@article{
author = "Papa, Anna and Božović, Bojana and Pavlidou, V. and Papadimitriou, E. and Pelemiš, Mijomir and Antoniadis, Antonis",
year = "2002",
abstract = "Crimean-Congo hemorrhagic fever virus (C-CHFV) strains were isolated from a fatal case and the attending physician in Kosovo, Yugoslavia. Early, rapid diagnosis of the disease was achieved by reverse transcription-polymerase chain reaction. The physician was successfully treated with oral ribavirin. These cases yielded the first genetically studied C-CHFV human isolates in the Balkans.",
publisher = "Centers for Disease Control and Prevention (CDC)",
journal = "Emerging Infectious Diseases",
title = "Genetic detection and isolation of Crimean-Congo hemorrhagic fever virus, Kosovo, Yugoslavia",
pages = "854-852",
number = "8",
volume = "8",
doi = "10.3201/eid0808.010448"
}

Papa, A., Božović, B., Pavlidou, V., Papadimitriou, E., Pelemiš, M.,& Antoniadis, A.. (2002). Genetic detection and isolation of Crimean-Congo hemorrhagic fever virus, Kosovo, Yugoslavia. in Emerging Infectious Diseases
Centers for Disease Control and Prevention (CDC)., 8(8), 852-854.
https://doi.org/10.3201/eid0808.010448

Papa A, Božović B, Pavlidou V, Papadimitriou E, Pelemiš M, Antoniadis A. Genetic detection and isolation of Crimean-Congo hemorrhagic fever virus, Kosovo, Yugoslavia. in Emerging Infectious Diseases. 2002;8(8):852-854.
doi:10.3201/eid0808.010448 .

Papa, Anna, Božović, Bojana, Pavlidou, V., Papadimitriou, E., Pelemiš, Mijomir, Antoniadis, Antonis, "Genetic detection and isolation of Crimean-Congo hemorrhagic fever virus, Kosovo, Yugoslavia" in Emerging Infectious Diseases, 8, no. 8 (2002):852-854,
https://doi.org/10.3201/eid0808.010448 . .